U.S. Industrials Stock News

Some Shopify Inc. ( NASDAQ:SHOP ) shareholders may be a little concerned to see that the Chief Operating Officer...

The Morning Bull - US Market Morning Update Tuesday, Dec, 16 2025 US stock futures are pointing higher this morning, with contracts tied to the S&P 500 up about half a percent, as investors weigh cooling but still elevated business costs against signs of resilience in housing. The latest New York manufacturing survey slipped back into contraction at minus 3.9, which means factories in that region are pulling back a bit, but it also showed that price pressures are easing, a mild positive for...

If you are wondering whether Nuvation Bio's explosive run means you are late to the party or looking at a genuine opportunity, let's break down what the current price might really be worth. The stock has been on a tear recently, with a 75.1% gain over the last month and a 228.6% jump year to date, even after a small 0.8% pullback over the past week. That surge has been fueled by growing optimism around Nuvation Bio's oncology pipeline and increasing investor attention on small cap biotech...

Veritone (VERI) has been on traders radar after a flurry of AI focused deals, from powering Strategic Communications JPS TRUST modernization program to teaming with Armada on edge to enterprise data workflows. See our latest analysis for Veritone. Despite a sharp pullback in the latest session, with a 1 day share price return of minus 8.79 percent and the stock closing at 5.19 dollars, Veritone still shows strong positive momentum. This is supported by a 30 day share price return of 20.70...

Halozyme Therapeutics (HALO) just added seasoned healthcare dealmaker Jim Lang to its board, and that move has investors asking whether fresh strategic eyes could help unlock more value after a mixed few months for the stock. See our latest analysis for Halozyme Therapeutics. The timing is interesting, as Halozyme’s share price sits at 63.45 dollars after a solid year to date share price return of just over 32 percent. However, the 3 year total shareholder return is a more modest 12 percent,...

It's been a soft week for Orion Energy Systems, Inc. ( NASDAQ:OESX ) shares, which are down 13%. But that doesn't...

If you have been wondering whether Archer-Daniels-Midland is still a value play or if the market has already priced in the upside, you are not alone. This stock sits at the crossroads of defensive staple and cyclical opportunity. After a choppy few years, the share price has quietly put together a solid run, up 3.9% over the last week, 2.7% over the past month, and roughly 20% year to date, while still sitting well below its levels from three years ago. Recent headlines around global grain...

Earlier this month, TETRA Technologies, Inc. announced a term sheet to form a joint venture with Magrathea Metals, Inc. to integrate clean magnesium production into its Evergreen bromine and critical minerals project in Southwest Arkansas, targeting domestic supply for defense and industrial uses. This planned collaboration not only broadens TETRA’s exposure to critical minerals like magnesium, lithium, and bromine, but also links the Evergreen Project directly to U.S. supply-chain and...

Those holding Olaplex Holdings, Inc. ( NASDAQ:OLPX ) shares would be relieved that the share price has rebounded 27% in...

Heron Therapeutics, Inc. ( NASDAQ:HRTX ) shares have had a really impressive month, gaining 27% after a shaky period...

Deckers Outdoor Corporation ( NYSE:DECK ) shareholders are no doubt pleased to see that the share price has bounced 26...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Key Insights Institutions' substantial holdings in First Bank implies that they have significant influence over the...

Some SkyWest, Inc. ( NASDAQ:SKYW ) shareholders may be a little concerned to see that the Independent Director...

Hongli Group Inc. ( NASDAQ:HLP ) shares have retraced a considerable 32% in the last month, reversing a fair amount of...

Wondering if Dolby Laboratories at around $66.62 is quietly turning into a value opportunity, or just a classic value trap in the making? The stock is down 14.4% year to date and 12.9% over the last year, even though it has inched up about 1.6% over the past month. This combination often signals shifting market expectations rather than a simple growth story. Recently, investors have been refocusing on Dolby's role as the audio and imaging standard across cinemas, streaming platforms, and...

If you are wondering whether Fifth Third Bancorp is still good value after its recent run up, or if you have missed the boat, you are in the right place to unpack what the current share price really implies. The stock has climbed 5.9% over the last week, 12.4% over the past month, and is now up 13.4% year to date, adding to an impressive 114.1% gain over five years that has clearly reshaped investor expectations. Recent attention on regional banks, tighter capital and liquidity standards,...

Fresh insider buying at MGM Resorts International (MGM), led by major holder IAC snapping up roughly 1.1 million shares, has put the spotlight back on the casino giant's digital and sports betting ambitions. See our latest analysis for MGM Resorts International. The fresh insider buying comes on the back of a solid run, with MGM’s share price delivering a low double digit year to date return and a mid single digit total shareholder return over the past year. This suggests momentum is quietly...

If you are wondering whether National Fuel Gas is still worth considering after its strong run, or if the easy money has already been made, you are not alone. The stock has climbed to around $82.40, up 1.1% over the last week, 1.7% over the last month, and 34.3% year to date, with a 39.1% gain over the past year and 133.9% over five years. That kind of steady outperformance has been supported by a favorable backdrop for US natural gas infrastructure and storage, as investors look for...

Astrana Health (ASTH) just got a fresh spotlight from Needham, which kicked off coverage by leaning into the company’s push toward value based care and full risk deals as a central long term growth story. See our latest analysis for Astrana Health. The mixed reaction to Needham’s upbeat initiation, combined with a recent earnings stumble and visible insider activity, helps explain why Astrana’s 30 day share price return is positive while its year to date share price return and one year total...

Crane NXT (CXT) has quietly slipped over the past month, but the underlying business is still growing, with revenue and earnings both moving in the right direction despite recent share price weakness. See our latest analysis for Crane NXT. That recent 1 month share price return of negative 15.16 percent, and a 1 year total shareholder return of negative 16.55 percent, suggests sentiment has become more cautious even as the business reports steady top and bottom line growth. If this kind of...

Many investors are asking whether Molson Coors Beverage at around $47.67 is a value opportunity or a value trap, and this breakdown is designed to provide a clearer perspective. The stock has bounced 5.4% over the last week and 2.6% over the past month, even though it is still down about 16.7% year to date and 16.6% over the last year. This pattern suggests sentiment may be shifting from overly pessimistic toward more cautious optimism. Recently, investors have been reacting to a mix of...

Alexandria Real Estate Equities recently cut its quarterly dividend by 45%, announced a new US$500 million share repurchase authorization after completing a prior US$258.25 million buyback, and disclosed the upcoming resignation of long‑time executive Daniel J. Ryan for personal and health reasons. These actions come as the company confronts multiple securities class action lawsuits tied to its Long Island City property, following weaker third‑quarter results, an impairment charge, and...

Wondering if Trip.com Group is still a smart way to play the travel recovery, or if most of the upside is already priced in? Let us unpack what the current share price is really implying about future growth. The stock has climbed 10.2% year to date to around $71.39, but it is still down 3.9% over the last year and roughly flat over the last month, suggesting investors are undecided about the next leg of the story. Sentiment has been shaped by ongoing recovery in global travel demand and...